Dr. Davies is a board certified urologist in Omaha, Nebraska practicing at The Urology Center, P.C., a private urology practice with offices in Omaha, Columbus, and western Iowa. He is also Clinical Assistant Professor of Surgery, Urology at The University of Nebraska Medical Center. Dr Davies treats the full spectrum of urologic conditions with special interest in urologic cancer, reconstructive surgery, and implant surgery. Dr Davies received thorough training in minimally invasive and Da Vinci robotic surgical procedures at Vanderbilt University Medical Center under the guidance of Dr Joseph A. Smith Jr, a pioneer in robotic surgery for prostate cancer.
Dr Davies is married and has four children, three daughters and a son. His hobbies include reading, good coffee, and spending time at the lake.
Educational Background
B.S.: University of Nebraska–Lincoln, Lincoln, NE, 2003
M.D.: University of Nebraska Medical Center, Omaha, NE, 2008
Urology Residency: Vanderbilt University Medical Center, 2008 – 2013
Certification
Board Certified, American Board of Urology, 2015
Research/Publications
Principal Investigator: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (SunRISe-3) Sunrise-3
Investigator: An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition). PSMAddition trial
Investigator: A Study of Apalutamide in Participants With High‑Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy (PROTEUS)
Investigator: Argos ADAPT Study of Dendritic Cell Immunotherapy in metastatic renal cell carcinoma
Davies JD, Chang SS. Office-Based Cystoscopy: Continued advances. In A.D. Smith, G.H. Badlani, et al. (Eds.), Smith’s Textbook of Endourology, 3rd Edition. Wiley-Blackwell: 2012.
Davies JD, Aghazadeh MA, Phillips S, Salem S, Clark PE, Cookson MS, Davis R, Herrell SD, Chang SS, Smith Jr, JA and Daniel A. Barocas. Prostate size as a predictor of Gleason score upgrading in low-risk prostate cancer patients. J Urol. 2011 Dec;186(6):2221-7.
Davies JD, Simons CM, Ruhotina N, Barocas DA, Clark PE and Todd M Morgan. Anatomical basis for lymph node counts as a measure of lymph node dissection extent: A cadaveric study. Urology. 2013 Feb;81(2):358-63.
Chang SS, Clark PE, Davies JD, Manoharan M, O’Brien TS, Patel A and Jinhai Fan. Screening, Diagnosis, and Evaluation: Endoscopic evaluation of the lower urinary tract. In M.S. Soloway and S. Khoury (Eds.), Bladder Cancer, 2nd Edition. ICUD-EAU: 2012.
Inman BA, Davies JD, Rangel LJ, Bergstralh EJ, Kwon ED, Blute ML, et al. Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level > or =50 ng/mL. Cancer. 2008 Oct 1;113(7):1544-51.
Awards
Phi Beta Kappa Society – 2002
CoSIDA Division I Football Academic All-American – 2003
University of Nebraska-Lincoln Male Student-Athlete of the Year – 2004
Dr. Prentice Gautt Big 12 Postgraduate Scholarship, 2003-04
Merit-Based Full Tuition Scholarship, University of Nebraska College of Medicine – 2005-06, 2006-07, 2007 – 08
Alpha Omega Alpha Honor Medical Society – 2007
Murphy Luncheon Attendee, American Urologic Association Annual Meeting, 2011
Entered private practice in 2013
Dr. Davies played for the Nebraska Cornhuskers from 1999-2004.